CN109125542A - A kind of drug for treating cardiovascular and cerebrovascular disease - Google Patents
A kind of drug for treating cardiovascular and cerebrovascular disease Download PDFInfo
- Publication number
- CN109125542A CN109125542A CN201811163410.2A CN201811163410A CN109125542A CN 109125542 A CN109125542 A CN 109125542A CN 201811163410 A CN201811163410 A CN 201811163410A CN 109125542 A CN109125542 A CN 109125542A
- Authority
- CN
- China
- Prior art keywords
- parts
- cerebrovascular disease
- cardiovascular
- drug
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/10—Peat; Amber; Turf; Humus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
- A61K36/835—Aquilaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
The present invention relates to technical field of pharmaceuticals, more particularly to a kind of drug for treating cardiovascular and cerebrovascular disease, raw material including following weight proportion: 45-55 parts of ginseng, 95-105 parts of Radix Salviae Miltiorrhizae, 15-25 parts of pheretima, 45-55 parts of agalloch eaglewood, 45-55 parts of Radix Notoginseng, 45-55 parts of amber, 45-55 parts of dragon's blood, 25-35 parts of Schisandra chinensis, it is reasonable that the present invention allots compatibility, monarch, collocation is rationally ingenious, while solving cardiovascular and cerebrovascular disease, can also capital stock training member, strengthening vital QI to eliminate pathogenic factors, fundamentally reducing fundamentally reduces or even prevents the possibility that cardiovascular and cerebrovascular disease recurs again.
Description
Technical field
The present invention relates to technical field of pharmaceuticals, and in particular to a kind of drug for treating cardiovascular and cerebrovascular disease.
Background technique
Cardiovascular and cerebrovascular disease is the general designation of cardiovascular and cranial vascular disease, is referred to since hyperlipidemia, blood are sticky, dynamic
The ischemic or hemorrhagic disease that heart caused by pulse atherosclerosis, hypertension etc., brain and body tissue occur.Heart and brain blood
Pipe disease is that one kind seriously threatens the mankind, and the common disease of especially 50 years old or more middle-aged and the old's health has high illness rate, high cause
The characteristics of residual rate and high mortality, even if the treatment means that application is most advanced, perfect at present, can still there is 50% or more the cerebrovascular
It is unexpected that survivor's life cannot take care of oneself completely, and the number that cardiovascular and cerebrovascular disease is died of in the whole world every year is up to 15,000,000 people, occupy each
The kind cause of the death is the first.The poisonous side effect of medicine of existing treatment cardiovascular and cerebrovascular disease is big, and big to kidney injury, therapeutic effect is poor, controls
The treatment period is long, increases burden of patients.
Summary of the invention
In order to solve shortcomings and deficiencies of the prior art, the present invention provides a kind of drug for treating cardiovascular and cerebrovascular disease, tool
There is the function of nourishing qi and blood, dredging collateral decompression, treats cardiovascular and cerebrovascular disease good effect, it is quick, it is without any side effects.
It is to solve technical solution used by its technical problem:
A kind of drug for treating cardiovascular and cerebrovascular disease, the raw material including following weight proportion: 45-55 parts of ginseng, Radix Salviae Miltiorrhizae 95-105
Part, 15-25 parts of pheretima, 45-55 parts of agalloch eaglewood, 45-55 parts of Radix Notoginseng, 45-55 parts of amber, 45-55 parts of dragon's blood, 25-35 parts of Schisandra chinensis.
Preferably, the raw material including following weight proportion: 50 parts of ginseng, 100 parts of Radix Salviae Miltiorrhizae, 20 parts of pheretima, 50 parts of agalloch eaglewood, three
7 50 parts, 50 parts of amber, 50 parts of dragon's blood, 30 parts of Schisandra chinensis.
The pharmacological action of each component in the present invention:
Ginseng: having adjustment blood pressure, restore cardiac function, neurasthenia and the diseases such as in poor health, also have eliminating the phlegm, stomach invigorating, diuresis,
Excitement and other effects；
The effect of Radix Salviae Miltiorrhizae: having promoting blood circulation, inducing meastruation to relieve menalgia, relieving restlessness and restlessness, cool blood to disappear carbuncle；
Pheretima: have effects that heat-clearing arresting convulsion, dredging collateral, relieving asthma, diuresis；.
Agalloch eaglewood: there is the effect of promoting qi circulation and relieving pain, warming middle energizer to arrest vomiting, gas of receiving is relievingd asthma；
Radix Notoginseng: there is dissipating stasis and stanching bleeding, detumescence ding-tong；
Amber: there is tranquillizing the mind by relieving convulsion, dissipating stasis and stanching bleeding, promoting diuresis for stranguria, go screen improving eyesight；
Dragon's blood: there is the effect of promoting blood circulation analgesic therapy, removing blood stasis and hemostasis, myogenic sore；
Schisandra chinensis: office, which has, astringes the lung to stop cough, nourishes the effect of arresting seminal emission, antidiarrheal hidroschesis.
The beneficial effects of the present invention are: the present invention provides a kind of pure Chinese medicine drug to alleviate, inhibit even to cure heart and brain blood
Pipe disease, the especially present invention use pure Chinese medicinal preparation, without toxic side effect.In addition, present invention allocation compatibility is reasonable, Jun Chenzuo
Make, collocation is rationally ingenious, while solving cardiovascular and cerebrovascular disease, moreover it is possible to capital stock training is first, strengthening vital QI to eliminate pathogenic factors, fundamentally reduce from
It fundamentally reduces and even prevents the possibility that cardiovascular and cerebrovascular disease recurs again.
Specific embodiment
Embodiment 1: a kind of drug for treating cardiovascular and cerebrovascular disease, the raw material including following weight proportion: 50 parts of ginseng, pellet
Join 100 parts, 20 parts of pheretima, 50 parts of agalloch eaglewood, 50 parts of Radix Notoginseng, 50 parts of amber, 50 parts of dragon's blood, 30 parts of Schisandra chinensis.
Embodiment 2: a kind of drug for treating cardiovascular and cerebrovascular disease, the raw material including following weight proportion: 45 parts of ginseng, pellet
Join 95 parts, 15 parts of pheretima, 45 parts of agalloch eaglewood, 45 parts of Radix Notoginseng, 45 parts of amber, 45 parts of dragon's blood, 25 parts of Schisandra chinensis.
Embodiment 3: a kind of drug for treating cardiovascular and cerebrovascular disease, the raw material including following weight proportion: 55 parts of ginseng, pellet
Join 105 parts, 25 parts of pheretima, 55 parts of agalloch eaglewood, 55 parts of Radix Notoginseng, 55 parts of amber, 55 parts of dragon's blood, 35 parts of Schisandra chinensis.
Claims (2)
1. a kind of drug for treating cardiovascular and cerebrovascular disease, which is characterized in that the raw material including following weight proportion: ginseng 45-55
Part, 95-105 parts of Radix Salviae Miltiorrhizae, 15-25 parts of pheretima, 45-55 parts of agalloch eaglewood, 45-55 parts of Radix Notoginseng, 45-55 parts of amber, 45-55 parts of dragon's blood,
25-35 parts of Schisandra chinensis.
2. a kind of drug for treating cardiovascular and cerebrovascular disease according to claim 1, which is characterized in that match including following weight
The raw material of ratio: 50 parts of ginseng, 100 parts of Radix Salviae Miltiorrhizae, 20 parts of pheretima, 50 parts of agalloch eaglewood, 50 parts of Radix Notoginseng, 50 parts of amber, 50 parts of dragon's blood, the five tastes
30 parts of son.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811163410.2A CN109125542A (en) | 2018-09-30 | 2018-09-30 | A kind of drug for treating cardiovascular and cerebrovascular disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811163410.2A CN109125542A (en) | 2018-09-30 | 2018-09-30 | A kind of drug for treating cardiovascular and cerebrovascular disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109125542A true CN109125542A (en) | 2019-01-04 |
Family
ID=64810726
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811163410.2A Pending CN109125542A (en) | 2018-09-30 | 2018-09-30 | A kind of drug for treating cardiovascular and cerebrovascular disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109125542A (en) |
-
2018
- 2018-09-30 CN CN201811163410.2A patent/CN109125542A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104013835A (en) | Traditional Chinese medicine for treating high blood pressure | |
| CN106620400A (en) | Wine drug for treating chronic pain damage | |
| CN103977251A (en) | Traditional Chinese medicine for treating heart-yang deficiency type arrhythmia | |
| CN101926867A (en) | Bone fracture recovering soup | |
| CN109125542A (en) | A kind of drug for treating cardiovascular and cerebrovascular disease | |
| CN104587225A (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
| CN103230535A (en) | Medicinal liquor with function of activating collaterals to ease pain | |
| CN102988473A (en) | Chinese medicament for treating hypertension | |
| CN103110843B (en) | Traditional Chinese medicine composition for treating hemorrhagic stroke | |
| CN105267703A (en) | Traditional Chinese medicine for treating cervical spondylosis | |
| CN105770251A (en) | Tongning capsule for treatment of cervical spondylosis, lumbar diseases and arthritis | |
| CN108938813A (en) | The Traditional Chinese medicine footbath agent and its application method for treating diabetes complicated property toe end necrosis | |
| CN114504635B (en) | Chinese patent medicine for treating apoplexy sequela | |
| CN103417788B (en) | One treats fracture Chinese medicine for oral administration | |
| CN101152329A (en) | Medicament for treating flab pain | |
| CN100594916C (en) | Plaster for reducing the blood pressure | |
| CN100512867C (en) | Traditional Chinese medicinal preparation for treating rheumatic arthritis, rheumatoid oarthritis, intervertebral disc and ischialgia neuralgia | |
| CN105770034A (en) | Chinese herbal preparation for treating femoral head necrosis and preparing method and application thereof | |
| CN105998716A (en) | Traditional Chinese medicine composition for treating impotence | |
| CN104306526A (en) | Traditional Chinese medicine composition for treating brachial plexus neuritis | |
| CN105687784A (en) | Traditional Chinese medicine for oral administration and plaster for treating cervical vertebra, scapulohumeral periarthritis and lumbar disc herniation | |
| CN105287979A (en) | External-application traditional Chinese medicine for treating cervical spondylosis | |
| CN103933176B (en) | A kind of Chinese medicine composition for the treatment of apoplexy sequela and preparation method thereof | |
| CN113940987A (en) | Traditional Chinese medicine liquor for treating bone fracture and preparation method thereof | |
| CN103861039A (en) | Bone-setting medicament and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190104 |